FSDDF - FSD Pharma to acquire Prismic Pharmaceuticals for $17.5M April, 23 2019 07:06 AM FSD Pharma Inc - Class B FSD Pharma (OTCQB:FSDDF) has agreed to acquire privately held Prismic Pharmaceuticals in an all-stock transaction valued at $17.5M.More news on: FSD Pharma Inc., Healthcare stocks news, Merger & acquisition news, Read more ...